Related Articles
Targeting transient receptor potential canonical 1 reduces non‑small cell lung cancer chemoresistance and stemness via inhibition of PI3K/AKT signaling
Combination of SN-38 with gefitinib or imatinib overcomes SN-38-resistant small-cell lung cancer cells
The combination effect of amrubicin with cisplatin or irinotecan for small-cell lung cancer cells
Effect of the p53α gene on the chemosensitivity of the H1299 human lung adenocarcinoma cell line
CD44 inhibition attenuates EGFR signaling and enhances cisplatin sensitivity in human EGFR wild‑type non‑small‑cell lung cancer cells